Health ❯Diabetes

Type 2 Diabetes

Obesity-related Cancers Big Brother Stigma Dietary Patterns Disease Management Health of Children Health Risks Body Image Market Performance Medication Risks

ACBP Protein Identified as Brake on Brown Fat Thermogenesis

The team aims to determine whether targeting ACBP can restore brown fat function to reduce obesity risk through novel therapies

Everyday Phytosterol Intake Reduces Heart Disease and Diabetes Risk, Study Finds

Daily Chickpeas and Black Beans Lower Cholesterol and Inflammation in Prediabetics

GLP-1 Drugs Linked to Lower Cancer Risk and Mortality in New Study

Study Highlights GADD45A's Role in Preventing Heart Failure

Adult-Onset Type 1 Diabetes Linked to Higher Heart Disease and Death Risks

Alison Hammond Details 11-Stone Weight Loss and Lifestyle Transformation

GLP-1 Drugs Found to Cut Alcohol Consumption and Improve Mental Health

UK Government Proposes Pharmacy Access for Weight-Loss Jabs Amid Rising Demand

Eric Stonestreet Opens Up About Type 2 Diabetes Journey and Mounjaro's Impact

Hypnotherapy Ends Father’s 14-Can-a-Day Pepsi Max Habit

Dual Brain Receptor Targeting Shows Promise for Enhanced Obesity Treatment

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials

Novo Nordisk Acquires Chinese Obesity Drug After CagriSema Trial Disappointment

Eli Lilly Launches Mounjaro in India to Address Obesity and Diabetes

Megan Stalter Criticizes Ozempic Use for Weight Loss

Study Investigates Vision Loss in Patients Using Popular Diabetes and Weight Loss Drugs

FDA Approves Ozempic to Reduce Kidney Disease Risks in Type 2 Diabetes Patients